Pharmacists involvement in HIV care and treatment has been shown to lead to clinically and statistically significant improvements in ART adherence, as well as greater viral load suppression for patients with HIV.
Outpatient ASPs remain crucial amid rising antimicrobial resistance.
Pharmacists can heighten awareness about cardiovascular health and promote heart-healthy lifestyles.
Acne is one of the most common conditions, with about 50 million Americans dealing with acne annually.
STRONG-HF aimed to study whether rapid-dose escalation of guideline-directed heart failure medications was more beneficial than usual care.
Many patients have baseline risk factors present at diagnosis because of older age and disease-related elements.
The role of monoclonal antibodies in minimizing COVID-19–related complications remains important to assess.
In Missouri, community health workers partnered with community pharmacists, CPESN, and others to develop a state-funded program to address vaccine gaps in local communities.
Medication therapy management reimbursement can be a driving factor to work toward statin implementation in this patient group.
REMS are not intended to minimize all harmful effects of a drug, but instead focus on preventing, tracking, and handling a specific serious risk by informing, educating, and/or enforcing measures that reduce the frequency and/or intensity of the event.
The use of adulterated cannabinoids mixed with insecticides is becoming more common.
FDA approval of 2-drug injectable Cabenuva is a game changer in maintaining viral suppression in patients.
Artificial intelligence holds immense potential to address the rising demand for oncology services and improve patient outcomes by facilitating more effective, efficient, personalized cancer care.
In an ambitious effort to address the ongoing uncertainty within the 340B Program space, 6 senators released a draft discussion bill earlier this year titled the SUSTAIN Act.
Low compensation, stressful environment spark technician exodus; replacing them has been difficult.
Environmental conditions and air pollution affect health by causing injuries and fatalities, exacerbating respiratory and cardiovascular diseases, and spreading infectious diseases.
Ambulatory infusion centers can help reduce the cost of care for payers and patients and allow pharmacists to contribute to a positive treatment experience.
Patients and other stakeholders need to be able to compare pharmacies based on standardized, transparent metrics with a measurement system to make informed decisions.
The agency is looking to regulate them as medical devices.
Five medications (tramadol, olanzapine, mirtazapine, bupropion, and atomoxetine) were associated with significantly better OUD remission.
In most patients who are pregnant or may become pregnant, warfarin is contraindicated due to increased risk of adverse fetal outcomes.
Pharmacists dispensing Lybalvi should understand that potentially life-threatening consequences can occur if opioids are taken concurrently.
Chicago Tribune investigation on pharmacists’ time and workload sparks new regulations.
Strong support from pharmacy professionals and a shift in systems and workflows help pave the way for success.
FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.
CMS Interim Final Rule on mandatory COVID-19 vaccinations for all facilities participating in Medicare and Medicaid potentially impacts pharmacies that provide services under a contract or arrangement with these facilities.
Having community pharmacists to influence outcomes associated with social determinants of health in the US population is vital to improving overall patient outcomes.
Building a team to support best practices, medication safety, and staff education can reduce risks.
Vanderbilt Specialty Pharmacy and Takeda Oncology are reaching across silos and entering an innovative partnership to improve patient care across the entire medication journey.